Baudax Bio, Inc. (BXRX)
Upgrades & Downgrades
Latest BXRX news
Baudax Bio, Inc. (BXRX) Reports Q2 Loss, Misses Revenue Estimates
11 August 2022
Baudax Bio, Inc. (BXRX) delivered earnings and revenue surprises of 17.32% and 61.04%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Baudax Bio to Present at the H.C. Wainwright Annual Global Life Sciences Conference
18 May 2022
MALVERN, Pa., May 18, 2022 (GLOBE NEWSWIRE) -- Baudax Bio, Inc. (NASDAQ:BXRX), a pharmaceutical company focused on innovative products for acute care settings, today announced that Gerri Henwood, the ...
Baudax Bio, Inc.'s (BXRX) CEO Gerri Henwood on Q1 2022 Results - Earnings Call Transcript
7 May 2022
Baudax Bio, Inc. (NASDAQ:BXRX ) Q1 2022 Earnings Conference Call May 5, 2022 8:30 AM ET Company Participants Sam Martin - Investor Relations Gerri Henwood - President and CEO Conference Call Participa...
Baudax Bio Announces Date of Reconvened Annual Meeting of Shareholders
5 May 2022
Annual Meeting to be reconvened on May 18, 2022 Annual Meeting to be reconvened on May 18, 2022
What Makes Baudax Bio, Inc. (BXRX) a New Strong Buy Stock
11 April 2022
Baudax Bio, Inc. (BXRX) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Baudax Bio (BXRX) Stock: 1-For-35 Reverse Stock Split Goes Into Effect
16 February 2022
A 1-for-35 reverse stock split of Baudax Bio Inc (NASDAQ: BXRX) has gone into effect. These are the details.
Can These Penny Stocks Climb This Week? 4 To Watch Right Now
23 January 2022
Are these penny stocks on your watchlist for next week? The post Can These Penny Stocks Climb This Week?
3 Penny Stocks Under $1 For You List This Week
20 January 2022
Penny stocks to watch today The post 3 Penny Stocks Under $1 For You List This Week appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
Baudax Bio to Present at the H.C. Wainwright BIOCONNECT Virtual Conference
4 January 2022
MALVERN, Pa., Jan. 04, 2022 (GLOBE NEWSWIRE) -- Baudax Bio, Inc. (NASDAQ:BXRX) a pharmaceutical company focused on commercializing and developing innovative products for acute care settings, today ann...